The α Chemokine, Interleukin 8, Inhibits the Antiviral Action of Interferon α |
| |
Authors: | Khalid S.A. Khabar Fahad Al-Zoghaibi Mohammed N. Al-Ahdal Tsugiya Murayama Mohammed Dhalla Naofumi Mukaida Mohammed Taha Sultan T. Al-Sedairy Yunus Siddiqui George Kessie Kouji Matsushima |
| |
Affiliation: | From the *Department of Biological and Medical Research, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia 11211; ‡Department of Microbiology, Kanazawa Medical University, Ishikawa 920-0; §Department of Pharmacology, Kanazwa University, Kanazawa 920; and ‖Department of Molecular Preventive Medicine, University of Tokyo, Tokyo 113, Japan |
| |
Abstract: | Interferon (IFN) exhibits a potent antiviral activity in vitro and plays a major role in the early defense against viruses. Like IFN, the proinflammatory chemokine, interleukin (IL)-8, is induced by viruses and appears in circulation during viral infections. In an in vitro cytopathic effect assay for IFN, we found that IL-8 can inhibit IFN-α activity in a dose-dependent manner. This action was reversed by specific monoclonal antibodies to IL-8. The chemokine was able to attenuate the IFN-mediated inhibition of viral replication as determined by measuring infectious virus yield. IL-8 also diminished the ability of IFN to inhibit an early stage of viral replication since IL-8 attenuated the inhibition of the formation of viral proteins. It appeared that IL-8 interfered with a late rather than an early step of IFN-mediated pathway such as early gene expression. The IL-8 inhibitory action on IFN-α antiviral activity was associated with reduced 2′,5′-A oligoadenylate synthetase activity, a pathway well correlative with the anti– encephalomyocarditis virus action of IFN-α. Understanding pathways that antagonize IFN action may lead to novel approaches to potentiate endogenous and therapeutic IFN. |
| |
Keywords: | |
|
|